{"id":"NCT03473223","sponsor":"CSL Behring","briefTitle":"Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome","officialTitle":"A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-03-21","primaryCompletion":"2023-02-16","completion":"2023-11-17","firstPosted":"2018-03-22","resultsPosted":"2025-01-14","lastUpdate":"2025-01-14"},"enrollment":18226,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Acute Coronary Syndrome"],"interventions":[{"type":"BIOLOGICAL","name":"Apolipoprotein A-I [human] (apoA-I)","otherNames":["CSL112"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"CSL112","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV events \\[MACE - cardiovascular (CV) death, myocardial infarction (MI), and stroke\\] in subjects with acute coronary syndrome (ACS) diagnosed with either ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI), including those managed with percutaneous coronary intervention (PCI) or medically managed.","primaryOutcome":{"measure":"Number of Participants With First Occurrence of Any Component of Composite MACE (CV Death, MI, or Stroke)","timeFrame":"From the time of randomization through 90 days","effectByArm":[{"arm":"CSL112","deltaMin":439,"sd":null},{"arm":"Placebo","deltaMin":472,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.121"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":903,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Bulgaria","Canada","Chile","Colombia","Croatia","Czechia","Denmark","Estonia","Finland","France","Georgia","Germany","Greece","Hong Kong","Hungary","Israel","Italy","Japan","Latvia","Lithuania","Malaysia","Mexico","Netherlands","New Zealand","Norway","Peru","Poland","Portugal","Romania","Russia","Serbia","Singapore","Slovakia","South Africa","South Korea","Spain","Sweden","Switzerland","Taiwan","Thailand","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["38587254","38588930","39230545"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1514,"n":9010},"commonTop":[]}}